Innovaderma PLC
LSE:IDP
Innovaderma PLC
LSE:IDP
Price:
29
GBX
Market Cap:
£8.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Innovaderma PLC
LSE:IDP
|
UK |
|
S
|
Sichuan Expressway Co Ltd
OTC:SEXHF
|
CN |
|
Everlight Electronics Co Ltd
TWSE:2393
|
TW |
Balance Sheet
Balance Sheet Decomposition
Innovaderma PLC
Innovaderma PLC
Balance Sheet Decomposition is not available for
Innovaderma PLC
Innovaderma PLC
Balance Sheet
Innovaderma PLC
Innovaderma PLC
Currency: GBP
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
2
|
4
|
2
|
2
|
|
| Cash |
0
|
0
|
0
|
0
|
2
|
1
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
2
|
2
|
1
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
2
|
2
|
3
|
1
|
2
|
|
| Accounts Receivables |
0
|
1
|
2
|
2
|
3
|
1
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
1
|
2
|
3
|
2
|
1
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
2
|
4
|
7
|
8
|
4
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
2
|
4
|
6
|
4
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Assets |
0
N/A
|
4
N/A
|
8
+104%
|
13
+55%
|
15
+16%
|
5
-65%
|
7
+33%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
2
|
2
|
3
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
0
|
2
|
3
|
3
|
4
|
3
|
4
|
|
| Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
2
N/A
|
3
+51%
|
3
-8%
|
4
+40%
|
4
-22%
|
4
+2%
|
|
| Equity | ||||||||
| Common Stock |
0
|
1
|
2
|
2
|
2
|
2
|
3
|
|
| Retained Earnings |
0
|
1
|
1
|
0
|
1
|
9
|
11
|
|
| Additional Paid In Capital |
0
|
1
|
4
|
8
|
8
|
8
|
11
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
2
N/A
|
5
+173%
|
10
+101%
|
10
+8%
|
2
-84%
|
3
+98%
|
|
| Total Liabilities & Equity |
0
N/A
|
4
N/A
|
8
+104%
|
13
+55%
|
15
+16%
|
5
-65%
|
7
+33%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
0
|
10
|
13
|
14
|
15
|
15
|
27
|
|
Switch to:
Switch to:
See Also
Discover More
